A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
Aims: To determine the long-term efficacy and safety of riboflavin/ultraviolet a corneal cross-linking (CXL) to halt the progression of keratoconus. Materials and methods: Thirty-five patients (35 eyes) who had undergone CXL with epithelial removal 5 or more years previously were examined.doi:10.5005/jp-journals-10025-1081 fatcat:in7oxcc43fffrpjg24lkphsxka